FindTrial
Sign In

Alitretinoin

DRUG16 trials

Sponsors

Universitair Medisch Centrum Groningen, Anderson Clinical Research, Basilea Pharmaceutica, Stiefel, a GSK Company, Technische Universität Dresden

Conditions

Atopic DermatitisEczemaHIV InfectionsHand DermatosesHand EczemaHand eczemaHepatic InsufficiencyLichen Planus (LP)

Phase 1

Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease
CompletedNCT01261923
University Hospital, Gentofte, CopenhagenHepatic Insufficiency
Start: 2010-12-31End: 2011-08-31Updated: 2013-01-29

Phase 2

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma
CompletedNCT00002188
Anderson Clinical ResearchHIV Infections, Sarcoma, Kaposi
Target: 27Updated: 2005-06-24
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis
CompletedNCT01245140
Stiefel, a GSK CompanyPsoriasis
Start: 2011-04-26End: 2014-04-16Updated: 2017-12-21
Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
TerminatedNCT01407679
University Hospital MuensterLupus Erythematosus, Cutaneous
Start: 2011-08-31End: 2014-04-30Updated: 2016-06-01
Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin
NCT01538732
University of ZurichLichen Planus (LP)
Start: 2012-03-31End: 2014-03-31Target: 20Updated: 2012-03-20

Phase 3

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
CompletedNCT00124436
Basilea PharmaceuticaHand Dermatoses
Start: 2005-03-31End: 2007-02-28Target: 300Updated: 2023-05-10
Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
CompletedNCT00124475
Basilea PharmaceuticaHand Dermatoses
Start: 2004-12-31End: 2007-09-30Target: 1035Updated: 2023-05-10
Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
CompletedNCT00309621
Basilea PharmaceuticaHand Dermatoses
Start: 2006-04-30End: 2007-05-31Target: 250Updated: 2023-05-10
Alitretinoin in the Treatment of Chronic Hand Eczema
CompletedNCT00519675
Basilea PharmaceuticaEczema
Start: 2007-05-31Target: 150Updated: 2023-05-10
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
CompletedNCT00817063
Stiefel, a GSK CompanyEczema
Start: 2009-01-08End: 2012-04-26Updated: 2020-04-27
Efficacy of oral alitretinoin versus oral azathioprine in patients with severe chronic non-hyperkeratotic hand eczema. A randomized prospective open-label trial with blinded outcome assessment.
Active, not recruitingNL-OMON41737
Universitair Medisch Centrum Groningenhand eczema
Start: 2016-05-09Target: 116Updated: 2024-02-28
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
NCT03026907
University Medical Center GroningenHand Eczema
Start: 2016-05-31End: 2019-12-31Target: 116Updated: 2018-05-04
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
NCT03026946
University Medical Center GroningenHand Eczema
Start: 2017-05-29End: 2022-07-31Target: 76Updated: 2019-02-26

Phase 4

Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
TerminatedNCT01231854
Technische Universität DresdenAtopic Dermatitis
Start: 2010-11-30End: 2013-03-31Updated: 2014-06-03
AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment
Not yet recruitingCTIS2024-515140-23-00
Universitair Medisch Centrum GroningenHand eczema
Target: 78Updated: 2024-11-08

Unknown Phase

A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
CompletedNCT00002439
Anderson Clinical ResearchHIV Infections, Sarcoma, Kaposi
Updated: 2005-06-24

Related Papers

Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment
BMJ Open2018-07-017 citations